International Pharmaceutical Expo (INTERPHEX), the premier pharmaceutical and biopharmaceutical development and manufacturing event, today announced the Rockwell Automation Center for The Connected Enterprise will be offering educational sessions during INTERPHEX 2015, April 21-23.
Experts will demonstrate how the latest automation and information technology, accelerated by advances in enabling technologies – including the Internet of Things, data analytics, remote monitoring and mobility – is improving collaboration and real-time decision making, and driving profitability in life sciences manufacturing.
“INTERPHEX attracts producers at the leading edge of their industry and manufacturing in general,” said John Genovesi, vice president and general manager, Information Software and Process, Rockwell Automation. “Most attendees are either participating in or closely following initiatives like the Smart Manufacturing Leadership Coalition, Industrie 4.0 and Smart Factories. But many don’t yet have a clear strategy in place to operationalize these initiatives.” Genovesi continued, “We are helping life sciences companies leverage manufacturing as a strategic business asset to stay ahead of consumer demand, improve traceability and reduce cycle times. What we are doing with The Connected Enterprise is creating a unified control and information system architecture to harness production intelligence and improve operations across the product life cycle – from formulation to factory.”
Presentations will be ongoing at the Rockwell Automation Center for The Connected Enterprise throughout the event. Rockwell Automation and industry experts will offer technical sessions open to all show attendees. Topics to be covered include:
- Deploying and migrating manufacturing execution systems (MES) in validated environments and ‘evergreen’ information software.
- Track and trace across hybrid discrete and process production.
- Serialization solutions and pending regulation.
- Quality and metrics that are changing the landscape of life sciences manufacturing.
- Mobilizing pharmaceutical production.
- Big data, cloud computing and manufacturing performance.
“This event is focused on continuous innovation. Having Rockwell Automation demonstrate how The Connected Enterprise better utilizes information from integrated systems was a clear fit for our audience,” said Ed Several, senior vice president and general manager, INTERPHEX. “We are certain that both exhibitors and key decision makers at INTERPHEX 2015 will benefit from seeing firsthand how industry leaders are moving ‘smart manufacturing’ from theory to practice.”
The Rockwell Automation Center for The Connected Enterprise will be located at the entrance to the Javits Center Lobby, Crystal Palace Booth 3. It will be open during show floor hours. Preregistration is not required for education sessions.
About Rockwell Automation
Rockwell Automation Inc. (NYSE: ROK), the world’s largest company dedicated to industrial automation and information, makes its customers more productive and the world more sustainable. Headquartered in Milwaukee, Wis., Rockwell Automation employs about 22,500 people serving customers in more than 80 countries.
INTERPHEX (International Pharmaceutical Expo), sponsored by Parenteral Drug Association (PDA), is the single source for complete biopharmaceutical development and manufacturing solutions to safely and cost effectively process all dosage forms for life-enhancing drugs. It brings over 12,000 global pharmaceutical and biotechnology professionals together with 600+ suppliers via 300,000 square feet of event space through a unique combination of exhibition, education, workshops, partnering opportunities and networking events. INTERPHEX offers annual national and international industry events and educational opportunities around the world. For more information, visit www.INTERPHEX.com and follow INTERPHEX on Facebook, LinkedIn, Twitter and YouTube. IPX Blog continues the learning beyond the show floor and INTERPHEX Connector is the new twice-weekly email industry insight and news briefing.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide.